Press Releases

All Releases
View Summary Five Prime Therapeutics, Inc. to Present at the 13th Annual BIO CEO & Investor Conference
Thursday, February 10, 2011
PDF 5.7 KB Add to Briefcase
View Summary Five Prime Therapeutics, Inc. to Present at Lazard Capital Markets 7th Annual Healthcare Conference
Tuesday, November 9, 2010
PDF 6.5 KB Add to Briefcase
View Summary Five Prime Therapeutics, Inc. Announces Relocation to South San Francisco
Tuesday, October 19, 2010
PDF 6.4 KB Add to Briefcase
View Summary Five Prime Therapeutics, Inc. to Present at Upcoming 9th Annual BIO Investor Forum
Tuesday, September 28, 2010
PDF 6.0 KB Add to Briefcase
View Summary Five Prime Therapeutics, Inc. Elects Franklin Berger To Its Board Of Directors
Monday, September 27, 2010
PDF 7.5 KB Add to Briefcase
View Summary Five Prime Therapeutics, Inc. Announces Issuance of Key Patents in the U.S. and Europe Covering Its Lead Oncology Drug
Tuesday, September 21, 2010
PDF 6.6 KB Add to Briefcase
View Summary FIVE PRIME THERAPEUTICS, INC. ANNOUNCES STRATEGIC ALLIANCE WITH GLAXOSMITHKLINE TO DISCOVER INNOVATIVE BIOLOGICS FOR SKELETAL MUSCLE DISORDERS
Tuesday, August 3, 2010
PDF 8.3 KB Add to Briefcase
View Summary Five Prime Therapeutics, Inc. and Fast Forward, LLC Collaborate to Speed New Treatments to People With Multiple Sclerosis
Tuesday, May 25, 2010
PDF 9.4 KB Add to Briefcase
View Summary Five Prime Therapeutics, Inc. to Present at Upcoming BIO International Convention
Thursday, April 29, 2010
PDF 6.1 KB Add to Briefcase
View Summary Five Prime Therapeutics, Inc. to Present at Upcoming Investor Conferences
Tuesday, March 2, 2010
PDF 6.7 KB Add to Briefcase
View Summary Five Prime Therapeutics, Inc. Announces Milestone for TherapeuticProgram
Wednesday, February 24, 2010
PDF 6.5 KB Add to Briefcase
View Summary Five Prime Therapeutics, Inc. to Present at Lazard Capital Markets 6th Annual Healthcare Conference
Wednesday, November 11, 2009
PDF 5.9 KB Add to Briefcase
View Summary Five Prime Therapeutics, Inc. Adds Key Leaders to Its Management Team
Thursday, October 15, 2009
PDF 6.8 KB Add to Briefcase
View Summary FivePrime Appoints Julia Gregory Chief Executive Officer and Member of Board of Directors
Tuesday, June 9, 2009
PDF 6.6 KB Add to Briefcase
View Summary FivePrime Initiates Phase 1 Clinical Trials of FP-1039 in Patients with Advanced Cancers
Monday, September 8, 2008
PDF 7.1 KB Add to Briefcase
View Summary FivePrime and Pfizer enter Oncology and Diabetes Collaboration
Tuesday, May 20, 2008
PDF 6.5 KB Add to Briefcase
View Summary FivePrime Reports Discovery of IL-34
Thursday, May 8, 2008
PDF 97.8 KB Add to Briefcase
View Summary FivePrime achieves target discovery milestone with Boehringer Ingelheim
Monday, October 1, 2007
PDF 5.2 KB Add to Briefcase
View Summary FivePrime enters Osteoarthritis and Pulmonary Fibrosis Collaboration with Centocor
Wednesday, January 3, 2007
PDF 6.1 KB Add to Briefcase
View Summary Mark McDade to join FivePrime Board of Directors
Monday, August 7, 2006
PDF 6.6 KB Add to Briefcase
Showing 161-180 of 182 Page: 1 ... 5 6 7 8 9 10  Previous 20 | Next 20
Add to Briefcase = add release to Briefcase

FPRX (Common Stock)

Exchange
NASDAQ
Price
46.02
Change (%)
-0.61
Volume
328,622

Data as of 3:47 PM ET on Wednesday, October 18, 2017
Minimum 20 minute delay
Refresh quote
Powered By eSignal, Inc.